logo
Plus   Neg
Share
Email
Comment

Pfizer Announces New Long-Term Relapse Prevention Data For PRISTIQ 50 Mg/day

Pfizer Inc. (PFE) announced new data on PRISTIQ (desvenlafaxine) Extended Release Tablets 50 mg/day for the treatment of major depressive disorder, or MDD, in adults, including a long-term relapse prevention study.

According to the company, these new data, and data from a study in peri- and post-menopausal women with MDD, add to the existing efficacy and safety profile of PRISTIQ for the treatment of MDD. Lastly, new data also provide information regarding the discontinuation of PRISTIQ 50 mg/day for the treatment of adults with MDD.

These new PRISTIQ 50 mg/day data focus on key factors - efficacy, safety, long-term use and discontinuation - that clinicians often consider when assessing antidepressants for the treatment of MDD.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Activist investor Bill Ackman's hedge fund Pershing Square Capital Management L.P. is cutting ten employees from its workforce, according to media reports, citing people with knowledge of the matter. The job cuts on Friday have reportedly brought the New York-based company's head count down to 46 and were mostly in the hedge fund's back-office and support staff. While reporting its fourth-quarter financial results on Tuesday, Kimberly-Clark Corp. said it will cut 5,000 to 5,500 jobs, or 12 to 13 percent of its workforce globally, under its 2018 Global Restructuring Program. In addition, Kimberly-Clark will close or sell about 10 manufacturing facilities and expand production capacity at several others to improve overall scale and costs. Verizon Communications Inc. (VZ) reported an adjusted fourth-quarter earnings per share of $0.86, flat with a year ago. On average, 24 analysts polled by Thomson Reuters expected the company to report profit per share of $0.88 for the quarter. Analysts' estimates typically exclude special items. Fourth-quarter...
comments powered by Disqus
Follow RTT